study_id,year,design,effect_type,effect_point,ci_low,ci_high,n_treat,n_ctrl,risk_of_bias,doi,journal_id,outcome,population,adverse_events,duration_weeks
MENT-RHOD-ANX_01,2011,randomized controlled trial,SMD,-0.3081,-0.4488,-0.1675,56,48,low,10.1055/s-0028-1088346,mental_health_journal,stress,Adults with stress concerns,None reported,9
MENT-RHOD-ANX_02,2012,randomized controlled trial,SMD,-0.3639,-0.5193,-0.2085,60,51,some concerns,10.3390/molecules27123823,mental_health_journal,stress,Adults with stress concerns,Mild GI discomfort,10
MENT-RHOD-ANX_03,2013,randomized controlled trial,SMD,-0.4083,-0.5556,-0.2610,64,54,mixed,10.1080/13651501.2017.1417442,mental_health_journal,stress,Adults with stress concerns,Transient headache,11
